Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis

Read more

India’s CRDMO sector growth potential at $22 – $25 bn by 2035: BCG-IPSO Report

Read more

Revamping multi-tier distribution: Ensuring consistent availability for India’s pharma growth

Read more

Leadership evolution in India’s pharma sector in 2025

Read more

India and Belgium unite to advance RNA-based vaccines

Read more

Jeff Bernstein joins Parexel’s Board of Directors

Read more

AstraZeneca gains CDSCO approval to import SZC for treating Hyperkalaemia in adult patients

Read more

Being complacent in pharma quality: Five minutes to midnight

Read more

Funding in pharma plummets by 85 per cent in Feb 2025

Read more

Belgian Economic Mission to India highlights collaborations in lifesciences sector

Read more